Peptides: The Science, Uses & Safety | Dr. Abud Bakri
Peptides are not just emerging therapeutics—they’re already reshaping human biology in ways that defy conventional medicine, with some compounds like BPC-157 and EDR (formerly pinealine) showing effects so potent they mimic evolutionary adaptations. Dr. Abud Bakri, a 33-year-old internal medicine physician and pioneer in peptide medicine, reveals that a single mid-sleep dose of EDR can triple REM sleep by epigenetically reprogramming brain metabolism—without binding to any known receptor—while BPC-157 accelerates tendon, nerve, and gut repair in animal models, despite lacking a defined receptor and having no FDA-approved human trials. These compounds are being used off-label by millions, often sourced from unregulated gray markets, creating a public health time bomb where profit-driven 'peptide tourism' outpaces science. Bakri warns that the real danger isn’t the peptides themselves, but the absence of clinical oversight, purity standards, and informed consent—especially as GLP-1 drugs now enable 30% weight loss, signaling a post-diet era where long-term safety, fertility, and neuroplasticity remain unknown. He calls for a physician-led, protocol-driven model where peptides are integrated into holistic health systems—sunlight, sleep, nutrition, and exercise first—rather than being treated as standalone biohacks.
A single mid-sleep dose of EDR (formerly pinealine) can triple REM sleep via epigenetic modulation of brain metabolism without binding to known receptors.
BPC-157 accelerates tendon, nerve, and gut healing in animal models despite lacking a known receptor and having no FDA-approved human trials.
Millions are using unregulated peptides like BPC-157 and EDR without clinical data, creating a public health risk due to counterfeit, contaminated, or mislabeled products.
GLP-1 drugs can reduce body weight by 10–30%, far exceeding diet and exercise alone, signaling a 'post-GLP-1 world' where traditional weight management is obsolete.
Long-term use of GLP-1s may be necessary for weight maintenance, but we don’t yet know if they can be safely discontinued or how they affect fertility and neuroplasticity.
…and 3 more takeaways available in PodZeus
The Rise of the Peptide Trinity
“People are now stacking their GLP-1 as their insulin sensitivity tool, their growth hormone or their GHRH and their antigen modulation therapies as this Trinity stack. Trinity stack? To get very fit, very healthy quickly.”
Peptides as Biological Languages
Dr. Bakri explains peptides as a fundamental language of the body, distinct from steroid hormones. He introduces a critical dichotomy: peptides with known receptors (like GLP-1s) versus those without (like BPC-157), which changes how we understand their clinical effects and safety profiles.
The Origins and Science of BPC-157
The history of BPC-157 is traced back to Pavlov’s gastric juice experiments and Soviet-era research on stress. The Croatian team isolated BPC-157 from a 40,000 Dalton protein, discovering its powerful regenerative effects in animal models—accelerating tendon, nerve, and gut healing.
The BPC-157 Safety Paradox
Despite no known receptor and minimal human data, BPC-157 shows no toxicity in animal studies—even at 1,000x the dose. However, its potential to promote angiogenesis raises concerns about fueling undetected tumors, a risk that remains unproven but untested in humans.
The Gray Market and Regulatory Wild West
The episode exposes the $5–10 billion gray market for peptides, where products labeled 'for research purposes only' are sold to consumers. Compounding pharmacies, often incentivized by kickbacks, sell unregulated versions, while the FDA’s shifting stance has created legal uncertainty.
“Lower mortality when it came to cardiovascular disease, infectious risk and for cancers. So Russian study caveat, but that would be the most interesting longevity study I've seen done if accurate, if true.”
“There's going to be protocols that develop. But I think within six months, there'll be very good physician options for everybody.”
“And once you get to above 40 amino acids, if you are a biologic, then the patent lasts. way longer. I don't know the exact numbers. Like 15 years? Yeah, much longer.”
Host
Guest
BPC-157
other
GLP-1
other
Dr. Abud Bakri
person
Andrew Huberman
person
Pinealine
other
Vladimir Cavinson
person
Dr. Aboud Bakri
person
Semaglutide
product
EDR
product
Thymulin
product
Eating for Better Sleep & Foods that Improve Metabolic Health | Dr. Marie-Pierre St-Onge
1h 57m • 6/8/2026
Peptides w/ Dr. Kyle Gillett, Doug Larson, Coach Travis Mash and Dr. Mike Lane #852
1h 0m • 6/10/2026
The Surgeon Defending Statins, GLP-1s, and Ancel Keys | Dr Terry Simpson
1h 42m • 6/1/2026
Reviewing the News w/ Cody Townsend, May 2026
1h 32m • 6/1/2026
How One Decision Can Change Everything Feat. Ken Rideout
59m • 6/2/2026
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime

